Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...
The market for Recombinant DNA Technology was valued at US$ 445 billion in 2021 and is anticipated to grow at a CAGR of 7.2% through 2032. Recombinant DNA technology’s introduction has changed how ...
The demand for the manufacturing of polypeptides has radically increased since the recent introduction of new diabetes, obesity and cardiovascular disease peptide drugs. Consequently, peptide API ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback